All fields are required.

quick contact

Cookie notice

We use cookies to personalize content and ads. They inter alia facilitate the provision of our services and help us with the payout of editorial and advertising content, and the analysis of user conduct in order to optimize our website. By using our services, you agree that we may use cookies. For further information please click here.

description

15th European Functional Drug Screening Symposium New INNOVATION in Technology and Application

25th June, 2019 - Barcelona, spain

  • Welcome

    We are delighted to invite you to the upcoming 15th European Functional Drug Screening Symposium which will be hosted at Hospital Sant Pau, Barcelona, Spain on 25 June 2019.

    Thanks to the FDSS community, this annual meeting provides the opportunity to discover new applications and innovative uses of the FDSS with thought leaders from academia, biotech and pharmaceutical industry.

    Here, you can find all the technical papers, posters and contents of past conferences.

    Topics:

    HTS using human iPSC-derived cells and new application of FDSS platform
    Sunao Hisada, Hamamatsu Photonics Japan
    Electrical stimulation of the MyoScreen platform with the FDSS/EFS: a new high-throughput screening platform for early muscle drug discovery
    Mélanie Flaender, CYTOO, France
    Ca2+ measurements in iPS derived skeletal muscle and neuronal cells
    Magdalena Koziczak, Novartis Pharma AG, Switzerland
    Novartis
    CNS.4U: A powerful tool in seizure liability studies
    Dietmar Hess, Ncardia, Cologne, Germany
    NCARDIA
    Bringing human neuronal biology to HTS: Functional Drug Screening with iCell GlutaNeurons and Astocyte on the Hamamatsu FDSS/µCELL
    Udo Kraushaar, NMI, Germany
    Cardiac safety profile for the H3 inverse agonist pitolisant: from preclinical to clinical data
    Thierry Calmels, Bioprojet Biotech, France
    Monitoring Functional Mechanisms of Protein Degradation using NanoLuc® Technologies
    Réka Nagy, Promega, Switzerland
    Enzyme complementation approaches to study NADPH oxidases
    Rochdi Bouhelal, Novartis Pharma AG, Basel, Switzerland
    Novartis
  • Contact:

    Jean Marc d'Angelo
    Phone: +33 (0) 6 25 50 12 45
    Mail: jmdangelo@hamamatsu.fr       

    or

    Corina Loepfe
    Phone: +41 (0)32 625 60 68
    Mail: corina.loepfe@hamamatsu.ch